highly significantP = .01
The only highly significant association with SM was pre-HCT cycles of chemotherapy (HR of 1.07 for each cycle of chemotherapy before HCT; 95% CI, 1.01-1.12; P = .01).
The only highly significant association with SM was pre-HCT cycles of chemotherapy (HR of 1.07 for each cycle of chemotherapy before HCT; 95% CI, 1.01-1.12; P = .01).